EHA Library - The official digital education library of European Hematology Association (EHA)

FREQUENCY OF RED CELL ANTIGENS AND ANTIBODIES IN THE POPULATION OF NORTH-EASTERN REGIONS OF RUSSIAN FEDERATION
Author(s): ,
Elena Butina
Affiliations:
immunogematology,Federal State Institute of Science “Kirov research Institute of Hematology and Blood Transfusion of the Federal Medical and Biological Agency of Russia”,Kirov,Russian Federation
,
Galina Zaitseva
Affiliations:
immunogematology,Federal State Institute of Science “Kirov research Institute of Hematology and Blood Transfusion of the Federal Medical and Biological Agency of Russia”,Kirov,Russian Federation
,
Tatiana Koryakovtseva
Affiliations:
immunogematology,Federal State Institute of Science “Kirov research Institute of Hematology and Blood Transfusion of the Federal Medical and Biological Agency of Russia”,Kirov,Russian Federation
Anastasia Karavaeva
Affiliations:
immunogematology,Federal State Institute of Science “Kirov research Institute of Hematology and Blood Transfusion of the Federal Medical and Biological Agency of Russia”,Kirov,Russian Federation
(Abstract release date: 05/19/16) EHA Library. Butina E. 06/09/16; 133136; E1587
Mrs. Elena Butina
Mrs. Elena Butina
Contributions
Abstract
Abstract: E1587

Type: Eposter Presentation

Background
Providing immunological compatibility of donor and recipient can prevent the development alloimmunization, the occurrence of hemolytic transfusion reactions and increase the effectiveness of transfusion therapy. The frequency of  red blood cell (RBC) antigens and alloantibodies is  different in populations from different races and geographic areas.

Aims
To study the  frequency of Rhesus phenotypes and RBC alloantibodies in donors and recipients of blood components residing in north-eastern regions of the Russian Federation .

Methods
Data from 8087 donors and 2648 patients with hematological diseases were analysed in 2009-2015. Research blood samples was carried out by erythrocyte-magnetized technology  (Diagast, France) and gel agglutination assay (BioRad, USA).

Results
Established following frequency  of Rhesus phenotypes: СсDее - 30.35%, ССDee – 19.39%, СсDЕе – 15.88%, ссddee – 15.34%, ccDEe – 13.00%, ccDEE – 3.24%, ccDee – 1.72%, Ccddee - 0.90%,  ccddEe – 0.07%,  CCddee – 0.05%, CcDEE – 0.05%, CCDEe – 0.02%, CCDEE – 0%, CCddEE – 0%.The incidence of RBC  antibodies in blood donors is very low (0.49%)   compared with the incidence in patients with hematological diseases, who received transfusion therapy  (1.93%) (p<0.01).  The most common specificities of antibodies in donors were anti-D (0.22%), in recipients - anti-E (0.3%), anti-K (0.26%), anti-D (0.23%). Differences in the frequency of anti-E and anti-K antibody in donors and recipients are significant (p <0.01) (table).Table. Frequency and specificity of RBC alloantibodies in blood donor and patients with hematological diseases
Specificity of RBC alloantibodiesFrequency of RBC alloantibodies (%)
donorspatients with hematological diseases
D0.210.23
DC0.020.08
C0.010.08
c00.08
E0.050.30*
Сw0.020.04
К0.020.26*
М0.020.11
Lea0.020.11
Leb0.020.08
Lua00.08
Fya00.04
Fyb0.010
Jkb0.010
* - The differences between the groups of donor and patients were significant (p <0.01)

Conclusion
In the population of north-eastern regions of Russian Federation  the most frequent phenotypes СсDee, ССDee, ссddee, СсDEe and anti-D, -E, -K alloantibodies. Analysis of immunohematological parameters of donors and recipients allows targeted collection, banking  and storage of blood components.

Session topic: E-poster

Keyword(s): Antibody, Phenotype, Red blood cell
Abstract: E1587

Type: Eposter Presentation

Background
Providing immunological compatibility of donor and recipient can prevent the development alloimmunization, the occurrence of hemolytic transfusion reactions and increase the effectiveness of transfusion therapy. The frequency of  red blood cell (RBC) antigens and alloantibodies is  different in populations from different races and geographic areas.

Aims
To study the  frequency of Rhesus phenotypes and RBC alloantibodies in donors and recipients of blood components residing in north-eastern regions of the Russian Federation .

Methods
Data from 8087 donors and 2648 patients with hematological diseases were analysed in 2009-2015. Research blood samples was carried out by erythrocyte-magnetized technology  (Diagast, France) and gel agglutination assay (BioRad, USA).

Results
Established following frequency  of Rhesus phenotypes: СсDее - 30.35%, ССDee – 19.39%, СсDЕе – 15.88%, ссddee – 15.34%, ccDEe – 13.00%, ccDEE – 3.24%, ccDee – 1.72%, Ccddee - 0.90%,  ccddEe – 0.07%,  CCddee – 0.05%, CcDEE – 0.05%, CCDEe – 0.02%, CCDEE – 0%, CCddEE – 0%.The incidence of RBC  antibodies in blood donors is very low (0.49%)   compared with the incidence in patients with hematological diseases, who received transfusion therapy  (1.93%) (p<0.01).  The most common specificities of antibodies in donors were anti-D (0.22%), in recipients - anti-E (0.3%), anti-K (0.26%), anti-D (0.23%). Differences in the frequency of anti-E and anti-K antibody in donors and recipients are significant (p <0.01) (table).Table. Frequency and specificity of RBC alloantibodies in blood donor and patients with hematological diseases
Specificity of RBC alloantibodiesFrequency of RBC alloantibodies (%)
donorspatients with hematological diseases
D0.210.23
DC0.020.08
C0.010.08
c00.08
E0.050.30*
Сw0.020.04
К0.020.26*
М0.020.11
Lea0.020.11
Leb0.020.08
Lua00.08
Fya00.04
Fyb0.010
Jkb0.010
* - The differences between the groups of donor and patients were significant (p <0.01)

Conclusion
In the population of north-eastern regions of Russian Federation  the most frequent phenotypes СсDee, ССDee, ссddee, СсDEe and anti-D, -E, -K alloantibodies. Analysis of immunohematological parameters of donors and recipients allows targeted collection, banking  and storage of blood components.

Session topic: E-poster

Keyword(s): Antibody, Phenotype, Red blood cell

By clicking “Accept Terms & all Cookies” or by continuing to browse, you agree to the storing of third-party cookies on your device to enhance your user experience and agree to the user terms and conditions of this learning management system (LMS).

Cookie Settings
Accept Terms & all Cookies